IE33175L - Sulphonamides. - Google Patents

Sulphonamides.

Info

Publication number
IE33175L
IE33175L IE690873A IE87369A IE33175L IE 33175 L IE33175 L IE 33175L IE 690873 A IE690873 A IE 690873A IE 87369 A IE87369 A IE 87369A IE 33175 L IE33175 L IE 33175L
Authority
IE
Ireland
Prior art keywords
alkyl
carbons
june
interrupted
alkoxy
Prior art date
Application number
IE690873A
Other versions
IE33175B1 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IE33175L publication Critical patent/IE33175L/en
Publication of IE33175B1 publication Critical patent/IE33175B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,268,835. Anti-diabetic sulpha-pyrimidines. SCHERING A.G. 16 June, 1969 [27 June, 1968], No. 30406/69. Heading A5B. [Also in Division C2] Pharmaceutical preparations having antidiabetic action contain as active ingredient compounds I (including salts with bases thereof) wherein R 1 and R 2 are H, halogen or C, to 4 alkyl, alkoxy or alkylmercapto, R 3 is alkyl or cycloalkyl with up to 8 carbons which may be interrupted by at least one oxygen or is alkoxy or cycloalkoxy with up to 8 carbons in which the alkyl or cycloalkyl fragment thereof may be interrupted by at least one oxygen, R 4 is H or C 1 to 4 alkyl, X signifies O, S or NH, Y is C 1 to 4 alkylene and n is 0 to 1 to 4. Bases, e.g. butyl biguanide, for salt formation may also possess a blood sugar-lowering action. Administration may be in the form of tablets, dragees, capsules, pills, suspensions or solutions. [GB1268835A]
IE873/69A 1968-06-27 1969-06-25 New sulphonamides having a blood sugar lowering action IE33175B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770731 DE1770731A1 (en) 1968-06-27 1968-06-27 New blood sugar lowering sulfonamides

Publications (2)

Publication Number Publication Date
IE33175L true IE33175L (en) 1969-12-27
IE33175B1 IE33175B1 (en) 1974-04-03

Family

ID=5700618

Family Applications (1)

Application Number Title Priority Date Filing Date
IE873/69A IE33175B1 (en) 1968-06-27 1969-06-25 New sulphonamides having a blood sugar lowering action

Country Status (14)

Country Link
AT (3) AT291256B (en)
BE (1) BE735287A (en)
BR (1) BR6908777D0 (en)
CH (1) CH518968A (en)
DE (1) DE1770731A1 (en)
DK (1) DK123602B (en)
ES (1) ES368100A1 (en)
FR (1) FR2014300B1 (en)
GB (1) GB1268835A (en)
IE (1) IE33175B1 (en)
IL (1) IL32396A (en)
NL (1) NL6909960A (en)
NO (1) NO124374B (en)
SE (1) SE357365B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2048906A1 (en) * 1970-10-06 1972-04-13 Boehringer Mannheim Gmbh, 6800 Mannheim Blood sugar lowering sulfonylaminopyrimidines and processes for their preparation
AU2003232551A1 (en) * 2002-06-13 2003-12-31 Qlt Inc. Methods of using isothiazole derivatives to treat cancer or inflammation

Also Published As

Publication number Publication date
FR2014300A1 (en) 1970-04-17
BR6908777D0 (en) 1973-01-23
SE357365B (en) 1973-06-25
DK123602B (en) 1972-07-10
GB1268835A (en) 1972-03-29
DE1770731A1 (en) 1971-11-25
IL32396A (en) 1972-06-28
AT291256B (en) 1971-07-12
IE33175B1 (en) 1974-04-03
ES368100A1 (en) 1971-05-01
AT289109B (en) 1971-04-13
CH518968A (en) 1972-02-15
AT291255B (en) 1971-07-12
NL6909960A (en) 1969-12-30
NO124374B (en) 1972-04-10
IL32396A0 (en) 1969-08-27
BE735287A (en) 1969-12-29
FR2014300B1 (en) 1973-01-12

Similar Documents

Publication Publication Date Title
GB1180766A (en) 2-Arylamine-1,3-Diazacycloalkenes-(2) and the Preparation Thereof
GB1334327A (en) Compositions for and method of combating virus infections
GB1192768A (en) N-Substituted 2,3,4,5,-Tetrahydro-1H-3-Benzazepines
GB1256849A (en)
IE33175L (en) Sulphonamides.
GB1491503A (en) Method of preventing and treating thrombosis
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
GB1407856A (en) Anti-inflammatory thiazole compositions and methods for using same
IE32495L (en) Sulphonamides
GB1319772A (en) Succinimides
GB1195319A (en) Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines
IE37186B1 (en) Improvements in and relating to the production of benzyl-pyrimidines
IE32669B1 (en) New benzenesulphonamide derivatives their production and compositions containing same
GB1377793A (en) Benzenesulphonamidopyrimidines and process for their manufacture
IE37288L (en) Crane assembly
ES383340A1 (en) P-(acetoacetamidoalkyl)benzenesulfonamide derivatives
GB1273399A (en) Novel formamido-cycloalkane derivatives
IE33995B1 (en) Bornanocarboxamides
IE35735B1 (en) Thiolcarbamates
GB1249447A (en) Sulphonylamino-pyrimidines
GB1390650A (en) Oxazines and thiazines
GB1125793A (en) Complexes of bismuth and chlorohydroxyquinoline and compositions containing them
GB1291524A (en) N-dialkoxyalkyl substituted phenethylamine derivatives
ES306518A1 (en) Neomycin pamoate
GB1242266A (en) (tetrachloro-fluoro-ethylthio) n-phenyl sulfonamides and their use in controlling pests